BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18469261)

  • 1. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Theurl M; Lederer D; Haufe H; Dietze O; Strasser M; Datz C; Weiss G
    Am J Clin Nutr; 2008 May; 87(5):1374-83. PubMed ID: 18469261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duodenal expression of iron transport molecules in patients with hereditary hemochromatosis or iron deficiency.
    Dostalikova-Cimburova M; Kratka K; Balusikova K; Chmelikova J; Hejda V; Hnanicek J; Neubauerova J; Vranova J; Kovar J; Horak J
    J Cell Mol Med; 2012 Aug; 16(8):1816-26. PubMed ID: 21973163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor alpha downregulates human hemojuvelin expression via a novel response element within its promoter.
    Salama MF; Bayele HK; Srai SS
    J Biomed Sci; 2012 Sep; 19(1):83. PubMed ID: 22998440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease.
    Boga S; Alkim H; Alkim C; Koksal AR; Bayram M; Yilmaz Ozguven MB; Tekin Neijmann S
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):293-300. PubMed ID: 26405701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload in adult Hfe-deficient mice independent of changes in the steady-state expression of the duodenal iron transporters DMT1 and Ireg1/ferroportin.
    Herrmann T; Muckenthaler M; van der Hoeven F; Brennan K; Gehrke SG; Hubert N; Sergi C; Gröne HJ; Kaiser I; Gosch I; Volkmann M; Riedel HD; Hentze MW; Stewart AF; Stremmel W
    J Mol Med (Berl); 2004 Jan; 82(1):39-48. PubMed ID: 14618243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis.
    Ludwiczek S; Theurl I; Bahram S; Schümann K; Weiss G
    J Cell Physiol; 2005 Aug; 204(2):489-99. PubMed ID: 15744772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin.
    Krijt J; Fujikura Y; Sefc L; Vokurka M; Hlobenová T; Necas E
    Physiol Res; 2010; 59(1):53-59. PubMed ID: 19249912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-regulatory gene expression during liver regeneration.
    Mollbrink A; Holmström P; Sjöström M; Hultcrantz R; Eriksson LC; Stål P
    Scand J Gastroenterol; 2012 May; 47(5):591-600. PubMed ID: 22364558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic iron metabolism gene expression profiles in HFE associated hereditary hemochromatosis.
    Gleeson F; Ryan E; Barrett S; Russell J; Crowe J
    Blood Cells Mol Dis; 2007; 38(1):37-44. PubMed ID: 17098454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional disruption of mouse HFE2 gene: maintenance of systemic iron homeostasis requires hepatic but not skeletal muscle hemojuvelin.
    Gkouvatsos K; Wagner J; Papanikolaou G; Sebastiani G; Pantopoulos K
    Hepatology; 2011 Nov; 54(5):1800-7. PubMed ID: 21748766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-HFE hepatic iron overload.
    Pietrangelo A; Caleffi A; Corradini E
    Semin Liver Dis; 2011 Aug; 31(3):302-18. PubMed ID: 21901660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis.
    Roetto A; Camaschella C
    Best Pract Res Clin Haematol; 2005 Jun; 18(2):235-50. PubMed ID: 15737887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway.
    Gehrke SG; Herrmann T; Kulaksiz H; Merle U; Bents K; Kaiser I; Riedel HD; Stremmel W
    Digestion; 2005; 72(1):25-32. PubMed ID: 16103673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis.
    Kawabata H; Fleming RE; Gui D; Moon SY; Saitoh T; O'Kelly J; Umehara Y; Wano Y; Said JW; Koeffler HP
    Blood; 2005 Jan; 105(1):376-81. PubMed ID: 15345587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis.
    Lee DH; Zhou LJ; Zhou Z; Xie JX; Jung JU; Liu Y; Xi CX; Mei L; Xiong WC
    Blood; 2010 Apr; 115(15):3136-45. PubMed ID: 20065295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    Marmur J; Beshara S; Eggertsen G; Onelöv L; Albiin N; Danielsson O; Hultcrantz R; Stål P
    BMC Gastroenterol; 2018 Jun; 18(1):78. PubMed ID: 29871592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathophysiology and genetics of classic HFE (type 1) hemochromatosis].
    Loréal O; Ropert M; Mosser A; Déhais V; Deugnier Y; David V; Brissot P; Jouanolle AM
    Presse Med; 2007 Sep; 36(9 Pt 2):1271-7. PubMed ID: 17521857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular pathogenesis of hereditary hemochromatosis.
    Babitt JL; Lin HY
    Semin Liver Dis; 2011 Aug; 31(3):280-92. PubMed ID: 21901658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.